Expect Deep and Sophisticated Advice and Counsel
Naveed Shams, MD, Ph.D. our Founding Manging Partner and CEO has thirty years’ experience in Academia and Industry, with 14 ophthalmic products launched worldwide across small and large biopharmaceutical companies, including LUCENTIS, the first truly effective anti-VEGF agent for the treatment of neovascular age-related macular degeneration, and Eyebelis, the first PGE2 receptor agonist for managing intraocular pressure. Extensive management experience in the USA, Europe, and Japan, as well as experience in creating companies in the Ophthalmic space, e.g., OnDemand Therapeutics, OPKO Health, Aavantgarde Bio.
Vision
To be the trusted leader in ophthalmic biopharmaceutical consulting, where science meets strategy to bring transformative therapies to patients worldwide.
Mission
To deliver bespoke creative strategies and tactics for efficient and rapid deployment of assets in the field of ophthalmic and vision sciences.
30+ years
Combined Global Experience
14
Ophthalmic Products Launched Globally
100%
Focus on Ophthalmic & Vision Sciences
Ready to elevate your project or need tailored consulting support?
Our team is here to listen, strategize, and deliver solutions aligned with your scientific and business objectives.